Washington Examiner
Sign in Subscribe
News
Politics
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
America at 250
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Protecting Air Ambulance Services
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Examining Transportation
Newsletters
Sign In Sign InHome
News
Politics
Policy2026 Election
Opinion
EditorialsOp-Eds
In FocusRestoring AmericaMagazineWatch
Sponsored
Protecting Air Ambulance ServicesPowering ProgressASAE – Association LeadershipNational ParksExamining Tax ReformFix TSCAInside the Corn BeltExamining Transportation
TWS Archive
Advertisement
Home › Tags › Posts tagged Pharmaceutical Industry

Tag: Pharmaceutical Industry

"This bill is a pale imitation of the original bill. It overpromises and underdelivers," said Sen. Dick Durbin, D-Ill., on the Senate floor Wednesday. (AP Photo) Healthcare

Democrats pile on criticism of Cures bill

Robert King · November 30, 2016 6:09 pm
The bill includes funding for President Obama's medical research initiatives, including $1.8 billion for the cancer moonshot, which seeks to conduct 10 years worth of cancer research in five. (AP Photo/Andrew Harnik) Healthcare

White House backs Cures bill

Robert King · November 30, 2016 2:12 am
Sen. Chuck Grassley, R-Iowa, said Tuesday he objected to a provision in a major medical research package that would have weakened the Sunshine Act, which discloses payments to doctors and healthcare companies. (AP Photo/Charlie Neibergall) Healthcare

Measure weakening transparency law dropped from Cures bill

Robert King · November 29, 2016 11:55 pm
Drugs have been carrying alarming costs, and health plans are increasingly asking people to shoulder a share of the price. (iStock photo) Beltway Confidential

How to combat soaring drug prices

Julia Michaloski · November 27, 2016 5:01 am
Beltway Confidential

Obama’s drug lobbyist passes back through the revolving door

Timothy P. Carney · November 17, 2016 12:50 am
Drug makers avoided a far-reaching set of proposals clamping down on the industry from Hillary Clinton. Healthcare

Drug industry scores with Trump victory

Robert King · November 10, 2016 5:01 am
This morning several major drug makers saw single digit gains as the New York Stock Exchange opened. (AP Photo/Rich Pedroncelli) Healthcare

Pharma company stocks go up after Trump win

Robert King · November 9, 2016 3:44 pm
Voters rejected a ballot referendum that would have capped drug prices for certain state programs. (AP Photo/Sue Ogrocki, File) Healthcare

California voters strike down drug prices cap

Robert King · November 9, 2016 3:26 pm
Gilead Sciences, which got into hot water with Congress a few years ago after releasing a pricey hepatitis C cure, contributed $4 million to the campaign. (AP Photo) Healthcare

Pharma’s $100 million West Coast battle

Robert King · November 7, 2016 5:01 am
Hospitalizations more than doubled from 1997 to 2012, mirroring an uptick in prescription painkiller use. (iStock photo) Healthcare

More kids hospitalized for opioid poisoning

Robert King · October 31, 2016 6:30 pm
The nonpartisan Kaiser Family Foundation's findings showed that average annual out-of-pocket spending on prescription drugs dropped from $167 in 2009 to $144 in 2014. (AP Photo) Healthcare

Out-of-pocket drug spending falls

Robert King · October 28, 2016 3:29 pm
Former presidential candidate Sen. Bernie Sanders, I-Vt., and Rep. Elijah Cummings, D-Md., sent a letter Thursday to Ariad Pharmaceuticals for answers about Iclusig, which treats a bone marrow cancer that makes too many white blood cells. (AP Photo/Jacquelyn Martin) Healthcare

Lawmakers target new high-priced drug

Robert King · October 20, 2016 6:27 pm
Advertisement
  • ‹Previous page
  • 1
  • …
  • 107
  • 108
  • 109
  • 110
  • 111
  • …
  • 142
  • ›Next page
Page 109 of 142
Advertisement
Washington Examiner Manage Preferences

News

  • Politics
    • White House
    • Senate
    • House
    • Campaigns
  • Business
  • World
  • Investigations
  • Justice
  • Supreme Court
  • Crime
  • Washington Secrets
  • Entertainment
  • Sports

Policy

  • Defense
  • National Security
  • Energy
  • Immigration
  • Finance and Economy
  • Healthcare
  • Foreign Policy
  • Tech
  • Infrastructure
  • Space

Commentary

  • Columnists
  • Editorials
  • Think Tanks
  • Beltway Confidential
  • Op-Eds

Restoring America

  • Patriotism & Unity
  • Faith, Freedom & Self-Reliance
  • Courage, Strength & Optimism
  • Equality, Not Elitism
  • Community & Family
  • Fairness & Justice
  • Mission

Watch

  • Shows
NEWSLETTERS MAGAZINE ARCHIVE
  • Policies and Standards
  • Terms Of Service
  • Subscription Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Transparency In Coverage
  • Advertise
  • Subscribe
  • Contact
  • Careers
  • Staff
  • About Examiner
  • Facebook
  • Twitter
© Copyright 2026. Washington Examiner. All Rights Reserved.
Advertisement